Epigenetics Drives Pharma Innovation - Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace. - BioPharm International

ADVERTISEMENT

Epigenetics Drives Pharma Innovation
Therapeutics targeting epigenetic mechanisms of disease will change the pharmaceutical marketplace.


BioPharm International
Volume 26, Issue 1, pp. 32-33

REFERENCES

1. M.E. Donohoe ME. Results Probl. Cell Differ. 55, 231–45 (2012).

2. K. Banno et al., Biochem. Res. Int. onlline, DOI :10.1155/2012/738274 738274, February, 2012.

3. Y. Boumber and J.P. Issa, Oncology 25 (3), 220–228 (2011).

4. P. Lopez-Serra and M. Esteller, Oncogene 31 (13), 1609–1622 (2012).

5. M. Esteller, N. Eng. J. Med. 358, 1148–1159 (2008).

6. P. Ao et al., Med. Hypotheses 70 (3), 678–684 (2008).

7. S.K. Bolta et al., Breast Cancer Res. Treat. 135 (3), 705–13 (2012).

8. Cai et al., Int. J. Mol. Sci. 12 (7), 4465–4487 (2012).

9. S.B. Baylin and P.A. Jones, Nat. Rev. Cancer 11 (10), 726–734 (2011).

10. M. Tessema et al., Carcinogenesis 30 (7), 1132–1138 (2009).

11. J.M Yingling JM, "The Changing Field of Drug Development," online Jul. 16, 2012. http://ecancer.org/tv/subject/611/1547/video.10 accessed Dec. 13, 2012.

12. P. Cuatrecasas, J. Clin. Invest. 116 (11), 2837–2842 (2006).

13. T. Kubota, K. Miyake, and T. Hirasawa, Clin. Epigenetics 4 (1), 1 (2012).

14. K.J. Morrow, Kalorama Reports, Pub ID: KLI3860511, pg. 160 (2012).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Lilly to Acquire Novartis Animal Health
April 22, 2014
Lilly to Acquire Novartis Animal Health
April 22, 2014
Novartis and GSK Trade Assets
April 22, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
Author Guidelines
Source: BioPharm International,
Click here